Dr. Jana Hyankova

PrimeVigilance Director and EU QPPV

Jana Hyankova is an expert in pharmacovigilance with more than 15 years of working experience from several global pharma companies.

Jana joined PrimeVigilance (former PharmInvent) in 2014 and she currently holds the position of PV Director. She serves as EU QPPV for several clients and conducts PV audits as requested by clients.

Prior to joining PrimeVigilance, she held managerial pharmacovigilance roles at Bristol Myers Squibb and PharmaSwiss SA after the acquisition of the company Valeant Pharmaceutical International. Jana has gained her medical education at Charles University in Prague and was working 8 years at the Institute for Clinical and Experimental Medicine as Researcher in the IT Department focusing on medical databases, Czech and EU financial projects and hospital IT systems development.

Outside of PrimeVigilance Jana is an active lecturer of Conforum, Institute of Pharmacovigilance and the Research Quality Association (RQA).

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services